IFN-γ Attenuates Eosinophilic Inflammation but Is Not Essential for Protection against RSV-Enhanced Asthmatic Comorbidity in Adult Mice
- PMID: 35062354
- PMCID: PMC8778557
- DOI: 10.3390/v14010147
IFN-γ Attenuates Eosinophilic Inflammation but Is Not Essential for Protection against RSV-Enhanced Asthmatic Comorbidity in Adult Mice
Abstract
The susceptibility to respiratory syncytial virus (RSV) infection in early life has been associated with a deficient T-helper cell type 1 (Th1) response. Conversely, healthy adults generally do not exhibit severe illness from RSV infection. In the current study, we investigated whether Th1 cytokine IFN-γ is essential for protection against RSV and RSV-associated comorbidities in adult mice. We found that, distinct from influenza virus, prior RSV infection does not induce significant IFN-γ production and susceptibility to secondary Streptococcus pneumoniae infection in adult wild-type (WT) mice. In ovalbumin (OVA)-induced asthmatic mice, RSV super-infection increases airway neutrophil recruitment and inflammatory lung damage but has no significant effect on OVA-induced eosinophilia. Compared with WT controls, RSV infection of asthmatic Ifng-/- mice results in increased airway eosinophil accumulation. However, a comparable increase in eosinophilia was detected in house dust mite (HDM)-induced asthmatic Ifng-/- mice in the absence of RSV infection. Furthermore, neither WT nor Ifng-/- mice exhibit apparent eosinophil infiltration during RSV infection alone. Together, these findings indicate that, despite its critical role in limiting eosinophilic inflammation during asthma, IFN-γ is not essential for protection against RSV-induced exacerbation of asthmatic inflammation in adult mice.
Keywords: RSV; asthma; comorbidity.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Combustion products of burn pit constituents induce more changes in asthmatic than non-asthmatic murine lungs.Part Fibre Toxicol. 2025 Jul 29;22(1):21. doi: 10.1186/s12989-025-00625-w. Part Fibre Toxicol. 2025. PMID: 40734182 Free PMC article.
-
CYP1B1 knockout enhanced IFN-γ production is required but not sufficient for protection of cigarette smoke-exposed mice against lethal influenza virus infection.Front Immunol. 2025 Jul 4;16:1600025. doi: 10.3389/fimmu.2025.1600025. eCollection 2025. Front Immunol. 2025. PMID: 40688072 Free PMC article.
-
Chemokine (C-X-C motif) ligand 11 is a crucial antiviral modulator that affects viral replication, the IFN-γ response, and T-cell functions during respiratory syncytial virus infection.J Immunol. 2025 Aug 1;214(8):1982-1999. doi: 10.1093/jimmun/vkaf098. J Immunol. 2025. PMID: 40447278
-
Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review.Expert Rev Clin Immunol. 2025 Jun;21(6):745-760. doi: 10.1080/1744666X.2025.2494658. Epub 2025 May 2. Expert Rev Clin Immunol. 2025. PMID: 40278893 Review.
-
Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.Health Technol Assess. 2008 Dec;12(36):iii, ix-x, 1-86. doi: 10.3310/hta12360. Health Technol Assess. 2008. PMID: 19049692
Cited by
-
Cordycepin, lactoferrin, and Sargassum fusiforme polysaccharides protects against RSV via M2-like macrophage polarization.Front Immunol. 2025 Jun 16;16:1576069. doi: 10.3389/fimmu.2025.1576069. eCollection 2025. Front Immunol. 2025. PMID: 40589746 Free PMC article.
-
Improvement of eosinophilic chronic rhinosinusitis after infection with severe acute respiratory syndrome corona virus 2 during dupilumab therapy: A case report.Front Allergy. 2023 Feb 2;4:1053777. doi: 10.3389/falgy.2023.1053777. eCollection 2023. Front Allergy. 2023. PMID: 36819831 Free PMC article.
-
Correlation analysis between the severity of respiratory syncytial virus pneumonia and the expression levels of inflammatory cytokines in bronchoalveolar lavage fluid among infants and young children.Front Pediatr. 2025 Feb 19;13:1482029. doi: 10.3389/fped.2025.1482029. eCollection 2025. Front Pediatr. 2025. PMID: 40046856 Free PMC article.
References
-
- Hall C.B., Weinberg G.A., Blumkin A.K., Edwards K.M., Staat M.A., Schultz A.F., Poehling K.A., Szilagyi P.G., Griffin M.R., Williams J.V., et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132:e341–e348. doi: 10.1542/peds.2013-0303. - DOI - PubMed
-
- Nguyen-Van-Tam J., Wyffels V., Smulders M., Mazumder D., Tyagi R., Gupta N., Gavart S., Fleischhackl R. Cumulative incidence of post-infection asthma or wheezing among young children clinically diagnosed with respiratory syncytial virus infection in the United States: A retrospective database analysis. Influenza Other Respir. Viruses. 2020;14:730–738. doi: 10.1111/irv.12770. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical